Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $675,688 | 207 | 77.4% |
| Travel and Lodging | $137,198 | 328 | 15.7% |
| Consulting Fee | $43,228 | 18 | 5.0% |
| Food and Beverage | $13,545 | 254 | 1.6% |
| Honoraria | $3,000 | 1 | 0.3% |
| Gift | $71.52 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $310,446 | 292 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $288,734 | 253 | $0 (2024) |
| Lilly USA, LLC | $118,344 | 112 | $0 (2024) |
| Janssen Biotech, Inc. | $65,632 | 44 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $61,217 | 37 | $0 (2024) |
| Celltrion USA Inc. | $16,551 | 16 | $0 (2024) |
| PFIZER INC. | $8,596 | 9 | $0 (2024) |
| Celgene Corporation | $2,462 | 22 | $0 (2024) |
| Medtronic, Inc. | $155.38 | 1 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $141.89 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $303,624 | 242 | Lilly USA, LLC ($89,001) |
| 2023 | $291,230 | 257 | AbbVie Inc. ($127,192) |
| 2022 | $220,148 | 234 | E.R. Squibb & Sons, L.L.C. ($125,153) |
| 2021 | $56,805 | 35 | AbbVie Inc. ($32,544) |
| 2019 | $87.27 | 3 | Celgene Corporation ($55.00) |
| 2018 | $184.37 | 15 | AbbVie, Inc. ($108.47) |
| 2017 | $651.51 | 23 | AbbVie, Inc. ($337.01) |
All Payment Transactions
809 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $904.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,550.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,036.50 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.69 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $904.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/05/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $904.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Travel and Lodging | In-kind items and services | $50.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $44.34 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Travel and Lodging | In-kind items and services | $44.22 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Travel and Lodging | In-kind items and services | $30.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $904.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,550.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,250.00 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $117.32 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Travel and Lodging | In-kind items and services | $770.14 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Travel and Lodging | In-kind items and services | $682.35 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $140.14 | General |
| Category: Immunology | ||||||
| 11/07/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,209.00 | General |
| Category: Neuroscience | ||||||
| 11/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,375.00 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $99.26 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 394 | 425 | $421,105 | $44,805 |
| 2022 | 7 | 291 | 344 | $302,664 | $39,143 |
| 2021 | 10 | 232 | 272 | $170,294 | $28,002 |
| 2020 | 6 | 103 | 107 | $87,465 | $10,169 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 82 | 82 | $125,970 | $14,010 | 11.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 57 | 72 | $35,740 | $7,882 | 22.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 40 | 53 | $27,485 | $5,790 | 21.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 71 | 71 | $101,494 | $3,882 | 3.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 24 | 24 | $17,112 | $3,275 | 19.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 54 | 54 | $66,736 | $2,869 | 4.3% |
| 45390 | Removal of large bowel tissue using a flexible endoscope | Facility | 2023 | 11 | 11 | $12,907 | $2,603 | 20.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 25 | $9,238 | $1,870 | 20.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 19 | 20 | $7,683 | $1,350 | 17.6% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 13 | 13 | $16,740 | $1,275 | 7.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 64 | 64 | $93,976 | $11,675 | 12.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 58 | 91 | $43,967 | $11,002 | 25.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 35 | 35 | $23,499 | $5,078 | 21.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 49 | $17,396 | $4,226 | 24.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 45 | 45 | $60,873 | $3,068 | 5.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 48 | 48 | $56,574 | $2,816 | 5.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $6,379 | $1,278 | 20.0% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 38 | 40 | $53,910 | $6,555 | 12.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 24 | 41 | $14,301 | $5,263 | 36.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 27 | 27 | $11,911 | $4,355 | 36.6% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 38 | 39 | $48,000 | $2,605 | 5.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 15 | 24 | $5,280 | $1,897 | 35.9% |
| 99358 | Prolonged patient service without direct patient contact first hour | Office | 2021 | 21 | 22 | $5,288 | $1,625 | 30.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 16 | $3,830 | $1,490 | 38.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 18 | 27 | $4,158 | $1,485 | 35.7% |
About Dr. George Salem, MD
Dr. George Salem, MD is a Gastroenterology healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2013. The National Provider Identifier (NPI) number assigned to this provider is 1659711356.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Salem, MD has received a total of $872,730 in payments from pharmaceutical and medical device companies, with $303,624 received in 2024. These payments were reported across 809 transactions from 20 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($675,688).
As a Medicare-enrolled provider, Salem has provided services to 1,020 Medicare beneficiaries, totaling 1,148 services with total Medicare billing of $122,119. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Other Specialties Internal Medicine
- Location Oklahoma City, OK
- Active Since 06/27/2013
- Last Updated 07/17/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1659711356
Products in Payments
- ZEPOSIA (Drug) $287,941
- RINVOQ (Biological) $168,300
- SKYRIZI (Biological) $111,920
- OMVOH (Drug) $77,312
- ENTYVIO (Biological) $61,217
- TREMFYA (Drug) $38,959
- STELARA (Biological) $26,815
- HUMIRA (Biological) $18,231
- ZYMFENTRA (Biological) $16,551
- VELSIPITY (Drug) $5,562
- XELJANZ (Drug) $3,000
- Humira (Biological) $198.04
- ENDOFLIP (Device) $155.38
- GATTEX (Drug) $85.20
- Erbe VIO3 (Device) $84.89
- SUTAB (Drug) $71.52
- Mavyret (Drug) $64.78
- Viekira (Drug) $45.95
- INJECTAFER (Drug) $37.18
- INFLECTRA (Biological) $33.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Oklahoma City
Tauseef Ali, M.d, M.D
Gastroenterology — Payments: $616,367
Pooja Singhal
Gastroenterology — Payments: $178,683
Matthew Mcbride, Md, MD
Gastroenterology — Payments: $83,407
Dr. Trushar Patel, M.d, M.D
Gastroenterology — Payments: $81,054
Dr. David Stokesberry, M.d, M.D
Gastroenterology — Payments: $41,079
Sanjay Sikka, M.d, M.D
Gastroenterology — Payments: $31,487